NCT00339963View on ClinicalTrials.gov

Genome Expression in Lymphoma, Leukemia and Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

1,340

Participants

Timeline

Start Date

November 9, 2001

Conditions
LeukemiaMultiple MyelomaHodgkin LymphomaLymphoma, Non-Hodgkin
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

Lymphoma/Leukemia Molecular Profiling Project (LLMPP)

UNKNOWN

lead

National Cancer Institute (NCI)

NIH

NCT00339963 - Genome Expression in Lymphoma, Leukemia and Multiple Myeloma | Biotech Hunter | Biotech Hunter